Financial News

My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

15.05 +0.25 (+1.72%)
Streaming Delayed Price Updated: 10:44 AM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Why Integra LifeSciences (IART) Stock Is Plunging Today
Integra LifeSciences Holdings Corp (NASDAQ: IART) reported  
Via Benzinga
First Republic Bank, Activision Blizzard, Enphase Energy And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded mixed, with the Nasdaq Composite gaining over 100 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Wall Street Is Bullish on GE HealthCare as It Invests in AI
The stand-alone company that spun off from GE in January is off to a good start. 
Via The Motley Fool
KB Home, Bed Bath & Beyond And 3 Stocks To Watch Heading Into Wednesday
With US stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
What 6 Analyst Ratings Have To Say About Integra Lifesciences
 
Via Benzinga
Integra LifeSciences Shares Surge On Q3 Beat
 
Via Benzinga
Expert Ratings for Integra Lifesciences
Within the last quarter, Integra Lifesciences (NASDAQ:IART) has observed the following analyst ratings: 
Via Benzinga
Analyst Ratings for Integra Lifesciences
Within the last quarter, Integra Lifesciences (NASDAQ:IART) has observed the following analyst ratings: 
Via Benzinga
Integra Lifesciences's Return On Capital Employed Overview
Pulled from Benzinga Pro data, Integra Lifesciences (NASDAQ:IART) posted Q3 earnings of $49.91 million, an increase from Q2 of 11.45%. Sales dropped to $385.19 million, a 3.17% decrease between... 
Via Benzinga
Integra Lifesciences: Q3 Earnings Insights
Integra Lifesciences (NASDAQ:IART) reported its Q3 earnings results on Wednesday, October 26, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
Integra LifeSciences Recalls CereLink Intracranial Pressure Monitors, Revises Guidance
 
Via Benzinga
4 Analysts Have This to Say About Integra Lifesciences
Over the past 3 months, 4 analysts have published their opinion on Integra Lifesciences (NASDAQ:IART) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Integra Lifesciences's Return on Invested Capital Insights
According to Benzinga Pro, during Q2, Integra Lifesciences (NASDAQ:IART) earned $44.79 million, a 36.13% increase from the preceding quarter. Integra Lifesciences also posted a total of $397.81 million... 
Via Benzinga
Piper Sandler Cuts Price Target For Integra Lifesciences As It Divests Wound Care Portfolio
 
Via Benzinga
Recap: Integra Lifesciences Q2 Earnings
  Integra Lifesciences (NASDAQ:IART) reported its Q2 earnings results on Wednesday, July 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022
Upgrades 
Via Benzinga
Integra LifeSciences Posts Street Beating Earnings, Backs FY22 Guidance
 
Via Benzinga
Looking Into Integra Lifesciences's Return On Capital Employed
According to Benzinga Pro, during Q1, Integra Lifesciences (NASDAQ:IART) earned $32.90 million, a 27.51% increase from the preceding quarter. Integra Lifesciences's sales decreased to $376.64 million,... 
Via Benzinga
Integra Lifesciences: Q1 Earnings Insights
Integra Lifesciences (NASDAQ:IART) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering... 
Via Benzinga
Recap: Integra Lifesciences Q4 Earnings
Integra Lifesciences (NASDAQ:IART) reported its Q4 earnings results on Wednesday, February 23, 2022 at 06:00 AM. Here's what investors need to know about the... 
Via Benzinga
Price Over Earnings Overview: Integra Lifesciences
Right now, Integra Lifesciences Inc. (NASDAQ:IART) share price is at $67.58, after a 1.75% decrease. Over the past month, the stock spiked by 1.91%, but over the past year... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Consumer Price Index
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Nasdaq jumped more than 200 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
Integra LifeSciences Reports Interim Q4 Sales Marginally Ahead Of Expectations
Integra LifeSciences Holdings Corp (NASDAQ: IART) expects Q4 FY21 sales of $404 million - $406 million, representing an increase of approximately 4% Y/Y on a reported... 
Via Benzinga
5 Stocks To Watch For January 12, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects Shaw Communications Inc. (NYSE: SJR) to report quarterly earnings at $0.29 per share on revenue... 
Via Benzinga
Here Are Answers for Shareholders After General Electric Breaks Up
Larry Culp was hired to save GE in 2018, but finally decided to break it up in order to unlock what's left of its value, especially in the healthcare unit. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021
Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ: 
Via Benzinga
Integra LifeSciences Stock Rises On Street-Beating Q3 Earnings, Raises FY21 EPS Guidance
Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares got a boost as Q3 adjusted EPS of $0.86 topped the consensus forecast of $0.72. Revenues increased... 
Via Benzinga
Integra LifeSciences Holdings Corporation (IART) Q3 2021 Earnings Call Transcript
IART earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback